Assort Health has announced a $120 million Series C financing round, valuing the patient access automation company at $1.2 billion. The funding increases the company’s total capital raised to more than $222 million and will support expansion of its AI-powered platform across large health systems following rapid commercial growth over the past 15 months.
The company’s platform is designed to automate patient access and administrative workflows beyond standalone conversational AI. Rather than treating each interaction independently, Assort Health’s proprietary Patient Journey Memory maintains a continuous patient record across scheduling, intake, eligibility verification, medication refills and payment processes, enabling AI agents to retain context throughout the care journey.
At the core of the platform is Synapse, Assort Health’s proprietary AI model developed specifically for specialty care. The model has been trained using 190 million patient voice interactions, 62,000 care protocols and 1.6 million decision pathways to support complex scheduling and workflow management across specialties including orthopedics, neurology and dermatology.
The integrated platform consists of four primary modules:
Concierge manages inbound patient calls, clinical triage, laboratory coordination and multilingual scheduling.
Activate conducts proactive outreach to close referral gaps, recover missed appointments and address outstanding balances.
Orchestrate automates administrative processes and documents encounters directly within electronic health record systems.
Empower provides operational staff with real-time performance insights and tools to develop customized AI agents.
According to the company, the platform has achieved 20-fold revenue growth during the past 15 months as deployments have expanded from large physician groups into enterprise health systems. California-based John Muir Health is among the organizations implementing the technology across its Epic and Athena environments. Assort Health reports that these deployments have contributed to a 115% increase in administrative labor capacity and a 5% absolute increase in net appointment volume while integrating with existing clinical workflows.
Commenting on the company’s progress, JP Sanday, who has joined Assort’s Board of Directors, said, “Every so often a company comes along that fundamentally reimagines how an industry operates. Assort is that company for healthcare. They’ve built not just another point solution, but a unified platform of AI agents that elevates the entire patient journey.”
Click here for the original news story.
